These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 5572580

  • 1. Relation between serum quinidine levels and renal function. Studies in normal subjects and patients with congestive failure and renal insufficiency.
    Bellet S, Roman LR, Boza A.
    Am J Cardiol; 1971 Apr; 27(4):368-71. PubMed ID: 5572580
    [No Abstract] [Full Text] [Related]

  • 2. Letter: Elimination of quinidine in congestive heart failure.
    Crouthamel WG.
    N Engl J Med; 1974 Jun 13; 290(24):1379-80. PubMed ID: 4827650
    [No Abstract] [Full Text] [Related]

  • 3. Quinidine elimination in patients with congestive heart failure or poor renal function.
    Kessler KM, Lowenthal DT, Warner H, Gibson T, Briggs W, Reidenberg MM.
    N Engl J Med; 1974 Mar 28; 290(13):706-9. PubMed ID: 4813743
    [No Abstract] [Full Text] [Related]

  • 4. The effect of congestive heart failure on quinidine pharmacokinetics.
    Crouthamel WG.
    Am Heart J; 1975 Sep 28; 90(3):335-9. PubMed ID: 1163425
    [Abstract] [Full Text] [Related]

  • 5. Digoxin-quinidine interaction in patients with renal failure.
    Hirschberg R, Schaefer K, von Herrath D, Kreutz G, Kewitz H.
    Klin Wochenschr; 1981 May 15; 59(10):521-2. PubMed ID: 7241953
    [Abstract] [Full Text] [Related]

  • 6. Clinical pharmacokinetics of quinidine.
    Ochs HR, Greenblatt DJ, Woo E.
    Clin Pharmacokinet; 1980 May 15; 5(2):150-68. PubMed ID: 6988137
    [Abstract] [Full Text] [Related]

  • 7. Serum concentration and urinary excretion of doxycline in normal subjects and patients with renal insufficiency.
    Ao NK, Taneja OP, Bhatia VN, Aggarwal DS.
    Chemotherapy; 1974 May 15; 20(3):129-40. PubMed ID: 4854258
    [No Abstract] [Full Text] [Related]

  • 8. [Significance of clearance values in advanced renal insufficiency (author's transl)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1978 Oct 27; 120(43):1419-24. PubMed ID: 101802
    [Abstract] [Full Text] [Related]

  • 9. Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure.
    Chan WW, Waltman Johnson K, Friedman HS, Navaratnam P.
    Hosp Pract (1995); 2016 Aug 27; 44(3):138-45. PubMed ID: 27292609
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
    Ueda CT, Dzindzio BS.
    Eur J Clin Pharmacol; 1979 Sep 27; 16(2):101-5. PubMed ID: 499305
    [Abstract] [Full Text] [Related]

  • 11. Serum digoxin concentration and age.
    Guggenheim R, Reidenberg MM.
    J Am Geriatr Soc; 1980 Dec 27; 28(12):553-5. PubMed ID: 7430533
    [Abstract] [Full Text] [Related]

  • 12. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE, Hager WD, Perrier D, Powell JR, Graves PE, Michael UF.
    Circulation; 1982 Dec 27; 66(6):1277-80. PubMed ID: 7139903
    [Abstract] [Full Text] [Related]

  • 13. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure.
    Pimstone B, Epstein S, Hamilton SM, LeRoith D, Hendricks S.
    J Clin Endocrinol Metab; 1977 Feb 27; 44(2):356-60. PubMed ID: 320223
    [Abstract] [Full Text] [Related]

  • 14. Quinidine kinetics in congestive heart failure.
    Ueda CT, Dzindzio BS.
    Clin Pharmacol Ther; 1978 Feb 27; 23(2):158-64. PubMed ID: 620475
    [No Abstract] [Full Text] [Related]

  • 15. The effect of doxycycline on renal function in patients with advanced renal insufficiency.
    Stenbaek O, Myhre E, Berdal BP.
    Scand J Infect Dis; 1973 Feb 27; 5(3):199-202. PubMed ID: 4767571
    [No Abstract] [Full Text] [Related]

  • 16. Protein restriction in chronic renal failure: correlation between creatinine clearance and the reciprocal serum creatinine.
    Rosman JB, Gretz N, van der Hem GK, Strauch M, Donker AJ.
    Contrib Nephrol; 1986 Feb 27; 53():74-81. PubMed ID: 3802825
    [No Abstract] [Full Text] [Related]

  • 17. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR, Vozeh S, Uematsu T, Guentert TW, Follath F.
    Clin Pharmacol Ther; 1987 Sep 27; 42(3):341-5. PubMed ID: 3621790
    [Abstract] [Full Text] [Related]

  • 18. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F, Arrobas M, Luna E, Naranjo M, Pizarro JL, Sánchez-Casado E.
    Nefrologia; 2002 Sep 27; 22(5):432-7. PubMed ID: 12497744
    [Abstract] [Full Text] [Related]

  • 19. Observations on methods of assaying, and the value of monitoring plasma quinidine concentrations.
    Abramson FP, Yago KB, Feuillan P.
    Res Commun Chem Pathol Pharmacol; 1979 Mar 27; 23(3):631-4. PubMed ID: 461980
    [No Abstract] [Full Text] [Related]

  • 20. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM, Leech RC, Spann JF.
    Clin Pharmacol Ther; 1979 Feb 27; 25(2):204-10. PubMed ID: 759074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.